A 12-year-old boy with 9-year history of DMD regains 30% motor function improvement after treatment at WMC: Pain eliminated and Post-activity palpitations stabilized.

Daghan Kuzucu, a lovely 12-year-old boy from Turkey, was unfortunately diagnosed with Duchenne Muscular Dystrophy. He had suffered from progressive limb weakness for 9 years and lost the ability to stand for more than 3 years. While lying in bed, he could neither move his legs horizontally nor lift them, nor could he turn over or sit up independently. When seated, his head and neck would droop feebly. He also experienced persistent spontaneous pain and tenderness all over his body and was prone to palpitations after minimal physical exertion.

Stem cell therapy for muscular dystrophy has gained worldwide popularity, yet not every stem cell hospital is capable of successfully admitting and providing effective treatment for patients with neuromuscular disorders. As a senior neuromedical expert and world-leading clinical specialist in stem cell therapy, Dr. Wu has dedicated over 20 years to researching and practicing the combined application of neural stem cells and mesenchymal stem cells + CAST therapy for neuromuscular diseases. Leveraging his extraordinary expertise and decades of clinical experience, Dr. Wu has helped numerous patients with various types of muscular dystrophy alleviate symptoms, enhance muscle strength, and improve motor function. Notably, many patients even witnessed a remarkable normalization of muscle volume in their atrophied or pseudohypertrophic limbs and trunks during their hospital stay.

After extensively researching WMC’s track record in treating muscular dystrophy and learning about Dr. Wu’s outstanding reputation in the global stem cell therapy field, Daghan Kuzucu’s parents arrived at WMC with the whole family’s hopes, eager to witness the medical miracle of stem cell therapy transform their beloved son’s condition.

Following 2 weeks of inpatient treatment, Daghan Kuzucu’s motor function improved dramatically.

Before treatment: His head and neck drooped feebly when seated.
After treatment: His head posture remained basically normal in a sitting position.

Before treatment: Proximal muscle strength of both upper limbs was Grade 1; distal muscle strength and grip strength were Grade 2+.
After treatment: Muscle strength of both upper arms reached Grade 2+; distal muscle strength of both forearms and grip strength of both hands improved to Grade 4, with a significant boost in movement flexibility.

Before treatment: He could not move his legs horizontally or lift them while lying down, nor could he turn over or sit up on his own.
After treatment: He gained the ability to move his legs horizontally in a supine position and lift his knees off the bed. He could slowly turn over, and his waist and abdominal strength improved significantly—he could now sit up independently from a 30-degree supine position, requiring much less assistance to rise from a flat-lying posture compared to his admission status.

Before treatment: Proximal and distal muscle strength of both lower limbs was Grade 1+.
After treatment: Muscle strength of both lower limbs increased to Grade 2+. He could lift both knees off the bed and independently control the direction of leg swings, with the right side performing slightly better than the left.

Before treatment: He suffered from frequent spontaneous systemic pain and tenderness, with palpitations triggered by light activity. His creatine kinase (CK) levels were significantly elevated.
After treatment: His systemic pain and tenderness were greatly relieved, with no discomfort during daily activities. His cardiac function improved, and his heart rate remained stable after physical exertion. His elevated CK levels also dropped significantly compared to the values measured upon admission.

We will continue to monitor Daghan Kuzucu’s motor function recovery to support his further progress.

We aspire to accompany more patients like Daghan Kuzucu, who are battling Duchenne Muscular Dystrophy, to experience the cutting-edge combined therapy of dual stem cells + CAST at WMC— a treatment distinct from traditional medicine. Our goal is to help them improve motor function, enhance quality of life, and rewrite their destinies.

To learn more information of Daghan Kuzucu’s patient story, please refer to the following link:
Daghan Kuzucu-Duchenne Muscular Dystrophy (DMD)-(Turkish)